Formation Bio announces a $600 million drug development accelerator fund

Formation Bio announced its debut Drug Development Accelerator Fund with $600 million in capital commitments, intended to acquire 10-15 drug programs over the next 3-5 years and advance them through clinical milestones using its AI-native development platform (October 28, 2026).